The Effect of Cardiac Rehabilitation on Oxidative DNA Damage and Inflammation in Patients With Coronary Artery Disease
NCT ID: NCT06867926
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2025-05-15
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early-phase Exercise-based Cardiac Rehabilitation After MI
NCT06924034
Evaluation of the Effects of Training at Different Intensities in Coronary Artery Patients
NCT06474624
Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
NCT05551429
Cardiac Rehabilitation in Coronary Artery Diseases
NCT05980364
Effects of Exercise Training on Endothelial Function, Inflammation, Arterial Stiffness and Autonomic Function in CAD
NCT01432639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recent research has focused on the impact of oxidative stress, genetic damage, and inflammation in CAD development. Chronic inflammation and oxidative stress can cause cellular damage by increasing the formation of free oxygen radicals. Oxidative stress leads to endothelial dysfunction, inflammation of the vessel wall, and the formation of atherosclerotic plaques. Atherosclerosis is the most common pathological process associated with cardiovascular diseases, and the disease is characterized by a high oxidative stress state, which causes lipid and protein oxidation. Oxidative stress and an imbalance between oxidants and antioxidants can damage important biomolecules such as DNA, lipids, and proteins.
Cardiac rehabilitation (CR) programmes are a recommended therapy with demonstrated efficacy in the treatment of patients with CAD. CR is a holistic approach that combines medical and exercise interventions to improve patients' cardiovascular health and general well-being. Exercise is the foundation of CR. While the literature describes it extensively, there is still some controversy surrounding oxidative stress and exercise. It has been suggested that exercise may increase the production of reactive oxygen molecules associated with oxidative stress, which is a factor in the pathogenesis of CAD. Regular and moderate exercise can have a positive impact on the body by balancing the production of antioxidants, reducing inflammation and oxidative stress. However, it is important to note that exercise should be approached in moderation to avoid any negative effects on the body. Previous studies have focused on risk factors associated with physical fitness, the fibrinolytic system, or lipid profile in cardiac patients. However, there have been relatively few investigations of induced changes in blood.
This study aims to investigate the role of oxidative stress and inflammation in the pathogenesis of CAD and the effects of KR on these pathophysiological processes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group for cardiac rehabilitation with coronary artery disease
Individuals diagnosed with coronary artery disease will engage in a programme of cardiac rehabilitation.
Cardiac rehabilitation
Individuals diagnosed with coronary artery disease will engage in a programme of cardiac rehabilitation.
Healthy control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac rehabilitation
Individuals diagnosed with coronary artery disease will engage in a programme of cardiac rehabilitation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who will undergo cardiopulmonary exercise testing before cardiac rehabilitation
3. Patients whose cognitive status is sufficient to complete the study and who can cooperate
1. 18 years of age or older
2. Not having a chronic disease (such as uncontrolled diabetes mellitus, hypertension, heart and kidney failure)
3. Not taking regular medication
Exclusion Criteria
2. Unstable Angina Pectoris
3. Complex ventricular arrhythmia
4. Having a pacemaker
5. Having orthopedic or neurological diseases that prevent exercise
6. Having kidney-liver disease
7. Exercise is contraindicated
8. History of inflammatory diseases
9. Having a history of cancer-immunologic disease
1. Having a history of chronic diseases such as diabetes mellitus, hypertension, heart and kidney failure
2. Being on regular medication for the last 6 months
3. being under 18 years of age
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan Kara
Professor Assistant Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University Faculty of Medicine
Kayseri, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKara3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.